Neck Pain, Pain in Arm, Unspecified
Conditions
Keywords
Cervical pain, Neck pain, Arm pain
Brief summary
The purpose of the Manual Cervical Distraction: Measuring Chiropractic Delivery for Neck Pain Clinical Trial is to examine the patient-centered clinical and biomechanical outcomes, doctor treatment delivery, and believability characteristics of a commonly used chiropractic procedure for the treatment of neck- or neck-related arm pain or disability.
Detailed description
The purpose of the Manual Cervical Distraction (MCD): Measuring Chiropractic Delivery for Neck Pain Clinical Trial is to examine the patient-centered clinical and biomechanical outcomes, and believability characteristics of a manually-localized cervical distraction procedure for the treatment of neck- or neck-related arm pain or disability. One challenging issue in the study of manual therapies, including spinal manipulation (SM), is the development of sham and/or minimal intervention procedures suitable for use with control groups in clinical trials. With SM, active treatment requires substantial physical contact between a study clinician and the study participant, either directly or through a mechanical intermediary. Consequently, it is difficult to introduce differences in manual therapy procedures that distinguish sham and/or minimal interventions from the active treatment, but are not immediately obvious to the study participant. Another challenging issue is training clinicians to deliver a standardized SM treatment within specified force ranges. The muscles surrounding the neck could alter the forces transmitted to the cervical spine, and could alter the treatment effectiveness. The purpose of this pilot randomized controlled trial is to examine the patient-centered clinical, biomechanical, and believability outcome characteristics of a manually-localized cervical distraction procedure for the treatment of neck or neck-related arm pain or disability. We also will evaluate the ability of the doctor of chiropractic to deliver the MCD treatment within specified force ranges. An exploratory aim of this study is to evaluate EMG measurement during MCD delivery.
Interventions
Manual Cervical Distraction (MCD) is a form of Low Velocity Variable Amplitude Spinal Manipulation (LVVA-SM). MCD procedure is performed with participant lying prone on a load instrumented table with moveable headpiece allowing guided head movement while recumbent. Clinician gently grasps posterior aspect of participant's neck with a broad contact (contact hand) between thumb and index finger at specific vertebral level. With opposite hand, clinician grasps control handle. Using contact hand, clinician exhibits superior traction to maintain a contact at a single vertebral level and ensuring a gentle movement via contact with control handle. Goal is to create a slow rhythmic (1-3 sec) localized distractive movement. In this trial, only axial distraction (Cox protocol 1) will be used.
Sponsors
Study design
Eligibility
Inclusion criteria
* Age 18 to 70 years (inclusive). * Mechanical neck pain or neck-related upper extremity pain lasting at least 4 weeks duration. * Mechanical neck pain or neck-related upper extremity pain classified as Quebec Task Force (QTF) 2-4. * Naïve to flexion-distraction manual therapy procedures to cervical area. * Average neck pain in the past 24 hours rated between 3 and 7 on a 0-10 Pain Numerical Rating Scale (NRS) at Phone Screen and Baseline 1 Interview. * Signed Informed Consent Document.
Exclusion criteria
* Doctor of chiropractic or current or former chiropractic student. * Average neck pain in past 24 hours rated 0-2 or 8-10 on a 0-10 Pain NRS at Phone Screen and Baseline 1 Interview. * Neck pain from other than somatic tissues as determined by history and clinical examination. * Surgery to cervical-thoracic area within the past 6 months. * Recent fracture in the cervico-thoracic spine or ribs within the past 8 weeks. * Injections for pain in neck, shoulders, arms or hands in the past 4 weeks. * Neck pain classified as QTF 1, 5-11. * Unwillingness to postpone use of all types of manual treatment for neck pain, except those provided in the study for the duration of the study. * Inability or unwillingness to comply with study protocols. * Bone or joint pathologies representing a contraindication to study procedures. * Any single or multisegmental fusion (surgical or congenital) of the 1st through the 7th cervical vertebrae. * Other safety concerns as determined by the clinical evaluation/opinion at case review. * Unable to tolerate study procedures. * Uncontrolled hypertension: systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg. * Simultaneous clinical management for a health condition that compromises ability to deliver study treatment or assess health status. * Inability to read or verbally comprehend English. * Drug or alcohol abuse or dependence, suspected or confirmed through self-report questionnaires and clinical interview. * Depression rated as ≥ 29 on the Beck Depression Inventory. * Cognitive or memory impairment identified during eligibility exam. * Pregnancy, under either of the following 2 circumstances: 1) Participant safety, if participant is unable to tolerate or undergo study procedures; or 2) Fetus safety, if x-rays are required for diagnosis. * Weight greater than 300 lbs (table weight limit). * Referral for evaluation, diagnosis, or management of other health conditions, or additional diagnostics required for neck pain diagnosis. * Retention of legal advice or seeking a health-related insurance claim. * Household member previously enrolled in MCD Clinical Trial. * Compliance concerns identified during baseline eligibility process.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Range of Traction Forces | Day 1, 4, 8, 11, 14 (Each Study Visit) | We will evaluate the clinician's ability to deliver three randomly assigned manual interventions to the cervical spine within specified traction force ranges (\<20 Newtons \[N\], 20-50N, \>50N). The primary outcome of this study is to determine the accuracy and consistency of traction force delivery ranges both between clinicians and within individual clinicians. Traction force ranges (C5 contact level and Occiput contact level) will be measured at each study visit (visits 1, 2, 3, 4, 5) for 2 weeks and averaged to calculate final outcome. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Neck Disability Index (NDI) | Change from Baseline to Day 1 (Study Visit 1) and Day 14 (Study Visit 5) | The NDI is a 10-item questionnaire modified from the Oswestry Low Back Pain Disability Index. The NDI has been shown to be a reliable and valid measure of disability due to neck pain, and responsive for measuring change. Study Visit 1 and Study Visit 5 Measures occur 2 weeks apart. The NDI scale is measured on a scale of 0-50, with 0 indicating no disability and 50 indicating complete disability. This measure is an adjusted mean NDI change. |
| Neck Pain Visual Analogue Scale (VAS) | Change from Baseline, Day 1, 4, 8, 11, 14 (Pre- and Post-Study Visits 1, 2, 3, 4, 5) | The VAS has excellent metric properties, is easy to administer and score (0-100mm), and is commonly used in pain research. Our anchors will be no pain (score of 0) to worst pain imaginable (score of 100). We will ask participants to rate their current neck pain at baseline and pre-/post-treatment for all 5 study visits. This measure is adjusted mean neck pain VAS change. A single value was calculated by averaging. |
| Patient Reported Outcomes Measurement Information System (PROMIS-43) | Change from Baseline to Day 14 (Study Visit 5) | The PROMIS-43 questionnaire will be used to measure general functional health status. PROMIS-43 questions measure physical function, anxiety, depression, fatigue, sleep disturbance, social role satisfaction, and pain interference and intensity. The table below displays the mean score at baseline. On the T-score metric & interpretation: * A score of 40 is one SD lower than the mean of the reference population (REF POP). * A score of 60 is one SD higher than the mean of the REF POP. * For PROMIS measures, higher scores equals more of the concept being measured (e.g., more Fatigue, more Physical Function). Thus a score of 60 is one SD above the average REF POP. This could be a desirable or undesirable outcome, depending upon the concept being measured. For Physical Function and Satisfaction with Social Role, higher scores reflect a better outcome, while for the remaining concepts, higher scores reflect a worse outcome. PROMIS - Pain Interference adjusted for baseline neck pain VAS. |
| Procedure Believability Questionnaire | Baseline (BL), Day 1 (Study Visit 1/T1), Day 14 (Study Visit 5/T5) | We will ask all participants whether they feel the study procedure would relieve their neck pain using the Procedure Believability Questionnaire. The response choices will be: Strongly believe the procedure will relieve my neck pain; Somewhat believe the procedure will relieve my neck pain; Somewhat believe the procedure will NOT relieve my neck pain; Strongly believe the procedure will NOT relieve my neck pain; and Don't know if the procedure will relieve my neck pain. A baseline (BL) evaluation will be completed based upon treatment description, and compared to assessments following study visit 1 (T1) and study visit 5 (T5) over a 2-week time period. |
| Credibility and Expectancy Questionnaire (CEQ) | Baseline, Day 1 (Study Visit 1), Day 14 (Study Visit 5) | The CEQ is a quick and easy-to-administer questionnaire for measuring treatment expectancy and rationale credibility of interventions for use in clinical outcome studies. Participants' perceptions of the study treatments were compared across groups using the CEQ. The CEQ credibility factor relates to how logical or believable a treatment is for the patient, whereas the expectancy factor refers to the patient's beliefs about improvements that might be achieved from the treatment \[61\]. CEQ scores for both the credibility and expectancy factors range from 3 to 27, with higher scores indicating greater belief in treatment credibility or expectancy for clinical improvement. |
| Cervical Range of Motion (cROM). | Change from Day 1 (Study Visit 1) to Day 14 (Study Visit 5) | Cervical ranges of motion are a measure of functional status and can be used to assess dysfunction in the cervical spine. Baseline/visit 1 (BL) cROM is displayed for Flexion-Extension, Lateral Bending, and Rotation. The mean change in cROM from visit 1 to visit 5 (V5 change) is also displayed. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Cervical Muscle Electromyographic (EMG) Activity | Day 8 (Study Visit 3), Day 11 (Study Visit 4) | We will describe electromyographic (EMG) activity of superficial neck muscles during delivery of the three manual interventions during visits 3 and 4. EMG measurements are an exploratory outcome variable in this study. RMS EMG TREATMENT DESCRIPTIONS: * (A) Ratio of Root Mean square (RMS) EMG during Treatment at C5/RMS EMG during maximum voluntary contraction (MVC) * (B) RMS EMG during Treatment at C5/RMS EMG during Prone Resting * (C) RMS EMG during Treatment at Occiput (OCC)/RMS EMG during MVC * (D) RMS EMG during Treatment at OCC/ RMS EMG during Prone Resting MUSCLES: * LES-Left erector Spinae Muscle * RES-Right Erector Spinae Muscle * LTRPS- Left Trapezius muscle * RTRPS- Right Trapezius Muscle * LSCM- Left Sternocleido Mastoid muscle * RSCM- Right Sternocleido Mastoid Muscle ACRONYM KEY: * RMS-Root Mean Square Value * MVC-Maximum Voluntary Contraction * C5-Cervical vertebrae contact * OCC-Occipital contact * EMG-Electromyographic activity |
| Patient Satisfaction Questionnaire | Day 14 (Study Visit 5) | Participants' satisfaction with study procedures and staff were assessed at Study Visit 5 using standard questions. Participants rated their satisfaction with various elements of the study (e.g., treatments received, clinicians) using a 5 category response from 1 (strongly satisfied) to 5 (strongly dissatisfied) with categories collapsed into satisfied (categories 1 and 2) or not satisfied (categories 3, 4 or 5) for interpretation. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Manual Cervical Distraction Low Force Manual Cervical Distraction (MCD) forces will be limited to less than 20N in the low force group. Dosing for this clinical trial is limited to 3 sets of 5 repetitions with a hand contact on one cervical vertebra of highest clinical importance and 3 sets of 5 repetitions with a hand contact on the occiput. | 16 |
| Manual Cervical Distraction Medium Force Manual Cervical Distraction(MCD) forces will be limited to between 20N-50N in the medium force group. Dosing for this clinical trial is limited to 3 sets of 5 repetitions with a hand contact on one cervical vertebra of highest clinical importance and 3 sets of 5 repetitions with a hand contact on the occiput. | 16 |
| Manual Cervical Distraction High Force Manual Cervical Distraction (MCD) forces will be limited to greater than 50N in the high force group. Dosing for this clinical trial is limited to 3 sets of 5 repetitions with a hand contact on one cervical vertebra of highest clinical importance and 3 sets of 5 repetitions with a hand contact on the occiput. | 16 |
| Total | 48 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 |
|---|---|---|---|---|
| Overall Study | Lost to Follow-up | 0 | 2 | 1 |
Baseline characteristics
| Characteristic | Manual Cervical Distraction Low Force | Manual Cervical Distraction Medium Force | Manual Cervical Distraction High Force | Total |
|---|---|---|---|---|
| Age, Continuous | 42.2 years STANDARD_DEVIATION 11.2 | 47.0 years STANDARD_DEVIATION 11.4 | 51.2 years STANDARD_DEVIATION 13.7 | 46.8 years STANDARD_DEVIATION 12.5 |
| Sex: Female, Male Female | 11 Participants | 12 Participants | 8 Participants | 31 Participants |
| Sex: Female, Male Male | 5 Participants | 4 Participants | 8 Participants | 17 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 16 | 0 / 16 | 0 / 16 |
| other Total, other adverse events | 6 / 16 | 10 / 16 | 10 / 16 |
| serious Total, serious adverse events | 0 / 16 | 0 / 16 | 0 / 16 |
Outcome results
Range of Traction Forces
We will evaluate the clinician's ability to deliver three randomly assigned manual interventions to the cervical spine within specified traction force ranges (\<20 Newtons \[N\], 20-50N, \>50N). The primary outcome of this study is to determine the accuracy and consistency of traction force delivery ranges both between clinicians and within individual clinicians. Traction force ranges (C5 contact level and Occiput contact level) will be measured at each study visit (visits 1, 2, 3, 4, 5) for 2 weeks and averaged to calculate final outcome.
Time frame: Day 1, 4, 8, 11, 14 (Each Study Visit)
Population: \*Cervical traction forces measured in Newtons (N) over four treatment visits for each participant. We recorded 23 missing values for traction forces due to 9 missing appointments (18 observations) and 5 instances of technical problems in data collection.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| MCD Low Force | Range of Traction Forces | C5 Contact Level | 13.82 Newtons (N) | Standard Deviation 5.74 |
| MCD Low Force | Range of Traction Forces | Occiput Contact Level | 17.19 Newtons (N) | Standard Deviation 4.84 |
| MCD Medium Force | Range of Traction Forces | C5 Contact Level | 38.3 Newtons (N) | Standard Deviation 12.12 |
| MCD Medium Force | Range of Traction Forces | Occiput Contact Level | 42.87 Newtons (N) | Standard Deviation 10.4 |
| MCD High Force | Range of Traction Forces | C5 Contact Level | 65.08 Newtons (N) | Standard Deviation 17.7 |
| MCD High Force | Range of Traction Forces | Occiput Contact Level | 74.06 Newtons (N) | Standard Deviation 16.08 |
Cervical Range of Motion (cROM).
Cervical ranges of motion are a measure of functional status and can be used to assess dysfunction in the cervical spine. Baseline/visit 1 (BL) cROM is displayed for Flexion-Extension, Lateral Bending, and Rotation. The mean change in cROM from visit 1 to visit 5 (V5 change) is also displayed.
Time frame: Change from Day 1 (Study Visit 1) to Day 14 (Study Visit 5)
Population: The number analyzed in row differs from overall due to:~1. Data collection issue due to equipment problems.~2. Participants did not show up for data collection.~3. 3 Participants were lost to follow up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| MCD Low Force | Cervical Range of Motion (cROM). | BL - Mean Flexion-Extension | 70.2 Degrees - Range of Motion | Standard Deviation 25.9 |
| MCD Low Force | Cervical Range of Motion (cROM). | BL - Mean Lateral Bending | 51.6 Degrees - Range of Motion | Standard Deviation 21.1 |
| MCD Low Force | Cervical Range of Motion (cROM). | BL - Mean Rotation | 88.5 Degrees - Range of Motion | Standard Deviation 25.4 |
| MCD Low Force | Cervical Range of Motion (cROM). | Mean Change from BL to V5 - Flexion-Extension | 0.8 Degrees - Range of Motion | Standard Deviation 14.9 |
| MCD Low Force | Cervical Range of Motion (cROM). | Mean Change from BL to V5 - Lateral Bending | -4.7 Degrees - Range of Motion | Standard Deviation 24.3 |
| MCD Low Force | Cervical Range of Motion (cROM). | Mean Change from BL to V5 - Rotation | 2.3 Degrees - Range of Motion | Standard Deviation 15.5 |
| MCD Medium Force | Cervical Range of Motion (cROM). | Mean Change from BL to V5 - Rotation | -8.9 Degrees - Range of Motion | Standard Deviation 28 |
| MCD Medium Force | Cervical Range of Motion (cROM). | BL - Mean Flexion-Extension | 75.4 Degrees - Range of Motion | Standard Deviation 32.4 |
| MCD Medium Force | Cervical Range of Motion (cROM). | Mean Change from BL to V5 - Flexion-Extension | 6.1 Degrees - Range of Motion | Standard Deviation 31.7 |
| MCD Medium Force | Cervical Range of Motion (cROM). | Mean Change from BL to V5 - Lateral Bending | -2.9 Degrees - Range of Motion | Standard Deviation 8.7 |
| MCD Medium Force | Cervical Range of Motion (cROM). | BL - Mean Lateral Bending | 54.7 Degrees - Range of Motion | Standard Deviation 12.1 |
| MCD Medium Force | Cervical Range of Motion (cROM). | BL - Mean Rotation | 91.1 Degrees - Range of Motion | Standard Deviation 22.8 |
| MCD High Force | Cervical Range of Motion (cROM). | BL - Mean Lateral Bending | 49.8 Degrees - Range of Motion | Standard Deviation 13.6 |
| MCD High Force | Cervical Range of Motion (cROM). | BL - Mean Rotation | 88.5 Degrees - Range of Motion | Standard Deviation 19.7 |
| MCD High Force | Cervical Range of Motion (cROM). | Mean Change from BL to V5 - Rotation | -8.1 Degrees - Range of Motion | Standard Deviation 37.5 |
| MCD High Force | Cervical Range of Motion (cROM). | Mean Change from BL to V5 - Flexion-Extension | 4.9 Degrees - Range of Motion | Standard Deviation 25.2 |
| MCD High Force | Cervical Range of Motion (cROM). | BL - Mean Flexion-Extension | 78.6 Degrees - Range of Motion | Standard Deviation 28.5 |
| MCD High Force | Cervical Range of Motion (cROM). | Mean Change from BL to V5 - Lateral Bending | -2.3 Degrees - Range of Motion | Standard Deviation 24.1 |
Credibility and Expectancy Questionnaire (CEQ)
The CEQ is a quick and easy-to-administer questionnaire for measuring treatment expectancy and rationale credibility of interventions for use in clinical outcome studies. Participants' perceptions of the study treatments were compared across groups using the CEQ. The CEQ credibility factor relates to how logical or believable a treatment is for the patient, whereas the expectancy factor refers to the patient's beliefs about improvements that might be achieved from the treatment \[61\]. CEQ scores for both the credibility and expectancy factors range from 3 to 27, with higher scores indicating greater belief in treatment credibility or expectancy for clinical improvement.
Time frame: Baseline, Day 1 (Study Visit 1), Day 14 (Study Visit 5)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| MCD Low Force | Credibility and Expectancy Questionnaire (CEQ) | Credibility Factor - Basline 1 Visit | 19.8 units on a scale (range 3-27) | Standard Deviation 2.2 |
| MCD Low Force | Credibility and Expectancy Questionnaire (CEQ) | Credibility Factor - Study Visit 1 | 15.5 units on a scale (range 3-27) | Standard Deviation 7 |
| MCD Low Force | Credibility and Expectancy Questionnaire (CEQ) | Credibility Factor - Study Visit 5 | 13.8 units on a scale (range 3-27) | Standard Deviation 8 |
| MCD Low Force | Credibility and Expectancy Questionnaire (CEQ) | Expectancy Factor - Baseline Visit 1 | 15.8 units on a scale (range 3-27) | Standard Deviation 4 |
| MCD Low Force | Credibility and Expectancy Questionnaire (CEQ) | Expectancy Factor - Study Visit 1 | 13.4 units on a scale (range 3-27) | Standard Deviation 6.2 |
| MCD Low Force | Credibility and Expectancy Questionnaire (CEQ) | Expectancy Factor - Study Visit 5 | 11.4 units on a scale (range 3-27) | Standard Deviation 7.8 |
| MCD Medium Force | Credibility and Expectancy Questionnaire (CEQ) | Expectancy Factor - Study Visit 5 | 15.1 units on a scale (range 3-27) | Standard Deviation 8.3 |
| MCD Medium Force | Credibility and Expectancy Questionnaire (CEQ) | Credibility Factor - Basline 1 Visit | 23.1 units on a scale (range 3-27) | Standard Deviation 3.4 |
| MCD Medium Force | Credibility and Expectancy Questionnaire (CEQ) | Expectancy Factor - Baseline Visit 1 | 19.7 units on a scale (range 3-27) | Standard Deviation 4.7 |
| MCD Medium Force | Credibility and Expectancy Questionnaire (CEQ) | Expectancy Factor - Study Visit 1 | 17.8 units on a scale (range 3-27) | Standard Deviation 5.8 |
| MCD Medium Force | Credibility and Expectancy Questionnaire (CEQ) | Credibility Factor - Study Visit 1 | 19.9 units on a scale (range 3-27) | Standard Deviation 5.2 |
| MCD Medium Force | Credibility and Expectancy Questionnaire (CEQ) | Credibility Factor - Study Visit 5 | 19.9 units on a scale (range 3-27) | Standard Deviation 7.5 |
| MCD High Force | Credibility and Expectancy Questionnaire (CEQ) | Credibility Factor - Study Visit 1 | 22.1 units on a scale (range 3-27) | Standard Deviation 4.8 |
| MCD High Force | Credibility and Expectancy Questionnaire (CEQ) | Credibility Factor - Study Visit 5 | 22.7 units on a scale (range 3-27) | Standard Deviation 4 |
| MCD High Force | Credibility and Expectancy Questionnaire (CEQ) | Expectancy Factor - Study Visit 5 | 17.8 units on a scale (range 3-27) | Standard Deviation 6.2 |
| MCD High Force | Credibility and Expectancy Questionnaire (CEQ) | Expectancy Factor - Baseline Visit 1 | 16.0 units on a scale (range 3-27) | Standard Deviation 6.9 |
| MCD High Force | Credibility and Expectancy Questionnaire (CEQ) | Credibility Factor - Basline 1 Visit | 21.0 units on a scale (range 3-27) | Standard Deviation 3.9 |
| MCD High Force | Credibility and Expectancy Questionnaire (CEQ) | Expectancy Factor - Study Visit 1 | 19.3 units on a scale (range 3-27) | Standard Deviation 6.7 |
Neck Disability Index (NDI)
The NDI is a 10-item questionnaire modified from the Oswestry Low Back Pain Disability Index. The NDI has been shown to be a reliable and valid measure of disability due to neck pain, and responsive for measuring change. Study Visit 1 and Study Visit 5 Measures occur 2 weeks apart. The NDI scale is measured on a scale of 0-50, with 0 indicating no disability and 50 indicating complete disability. This measure is an adjusted mean NDI change.
Time frame: Change from Baseline to Day 1 (Study Visit 1) and Day 14 (Study Visit 5)
| Arm | Measure | Value (MEAN) |
|---|---|---|
| MCD Low Force | Neck Disability Index (NDI) | 1.3 units on scale |
| MCD Medium Force | Neck Disability Index (NDI) | 4.2 units on scale |
| MCD High Force | Neck Disability Index (NDI) | 4.0 units on scale |
Neck Pain Visual Analogue Scale (VAS)
The VAS has excellent metric properties, is easy to administer and score (0-100mm), and is commonly used in pain research. Our anchors will be no pain (score of 0) to worst pain imaginable (score of 100). We will ask participants to rate their current neck pain at baseline and pre-/post-treatment for all 5 study visits. This measure is adjusted mean neck pain VAS change. A single value was calculated by averaging.
Time frame: Change from Baseline, Day 1, 4, 8, 11, 14 (Pre- and Post-Study Visits 1, 2, 3, 4, 5)
| Arm | Measure | Value (MEAN) |
|---|---|---|
| MCD Low Force | Neck Pain Visual Analogue Scale (VAS) | 9.1 mm |
| MCD Medium Force | Neck Pain Visual Analogue Scale (VAS) | 18.9 mm |
| MCD High Force | Neck Pain Visual Analogue Scale (VAS) | 24.7 mm |
Patient Reported Outcomes Measurement Information System (PROMIS-43)
The PROMIS-43 questionnaire will be used to measure general functional health status. PROMIS-43 questions measure physical function, anxiety, depression, fatigue, sleep disturbance, social role satisfaction, and pain interference and intensity. The table below displays the mean score at baseline. On the T-score metric & interpretation: * A score of 40 is one SD lower than the mean of the reference population (REF POP). * A score of 60 is one SD higher than the mean of the REF POP. * For PROMIS measures, higher scores equals more of the concept being measured (e.g., more Fatigue, more Physical Function). Thus a score of 60 is one SD above the average REF POP. This could be a desirable or undesirable outcome, depending upon the concept being measured. For Physical Function and Satisfaction with Social Role, higher scores reflect a better outcome, while for the remaining concepts, higher scores reflect a worse outcome. PROMIS - Pain Interference adjusted for baseline neck pain VAS.
Time frame: Change from Baseline to Day 14 (Study Visit 5)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Anxiety (Day 14) | 45.3 T-score | Standard Deviation 9.8 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Fatigue (baseline) | 50.4 T-score | Standard Deviation 10.9 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Satisfaction with Social Role (baseline) | 51.7 T-score | Standard Deviation 8.5 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Anxiety (baseline) | 46.8 T-score | Standard Deviation 10.9 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Fatigue (Day 14) | 53.8 T-score | Standard Deviation 12.6 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Pain Interference (Day 14) | 50.0 T-score | Standard Deviation 8.4 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Sleep Disturbance (Day 14) | 51.2 T-score | Standard Deviation 2.6 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Sleep Disturbance (baseline) | 51.3 T-score | Standard Deviation 3 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Depression (Day 14) | 42.8 T-score | Standard Deviation 6.3 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Physical Function (baseline) | 27.7 T-score | Standard Deviation 5.2 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Pain Interference (baseline) | 53.2 T-score | Standard Deviation 6.7 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Depression (baseline) | 42.6 T-score | Standard Deviation 6.8 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Physical Function (Day 14) | 27.2 T-score | Standard Deviation 6.3 |
| MCD Low Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Satisfaction with Social Role (Day 14) | 50.9 T-score | Standard Deviation 11.2 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Sleep Disturbance (baseline) | 51.3 T-score | Standard Deviation 3 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Pain Interference (baseline) | 54.9 T-score | Standard Deviation 5.2 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Pain Interference (Day 14) | 49.6 T-score | Standard Deviation 7.5 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Physical Function (baseline) | 25.3 T-score | Standard Deviation 5 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Physical Function (Day 14) | 25.7 T-score | Standard Deviation 4.8 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Fatigue (baseline) | 46.4 T-score | Standard Deviation 9.3 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Fatigue (Day 14) | 47.0 T-score | Standard Deviation 6.4 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Anxiety (baseline) | 47.5 T-score | Standard Deviation 8 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Anxiety (Day 14) | 46.2 T-score | Standard Deviation 7.2 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Depression (baseline) | 43.9 T-score | Standard Deviation 7.8 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Depression (Day 14) | 42.1 T-score | Standard Deviation 5.6 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Satisfaction with Social Role (baseline) | 53.6 T-score | Standard Deviation 7.6 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Satisfaction with Social Role (Day 14) | 55.2 T-score | Standard Deviation 8 |
| MCD Medium Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Sleep Disturbance (Day 14) | 52.6 T-score | Standard Deviation 4.1 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Physical Function (baseline) | 26.4 T-score | Standard Deviation 4.5 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Sleep Disturbance (baseline) | 51.5 T-score | Standard Deviation 2.6 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Depression (baseline) | 43.6 T-score | Standard Deviation 5.5 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Pain Interference (Day 14) | 51.6 T-score | Standard Deviation 4.9 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Sleep Disturbance (Day 14) | 49.8 T-score | Standard Deviation 2.4 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Depression (Day 14) | 40.4 T-score | Standard Deviation 4.6 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Pain Interference (baseline) | 51.2 T-score | Standard Deviation 5.6 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Fatigue (Day 14) | 45.6 T-score | Standard Deviation 7.4 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Fatigue (baseline) | 47.1 T-score | Standard Deviation 7.2 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Satisfaction with Social Role (Day 14) | 53.4 T-score | Standard Deviation 8.5 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Anxiety (baseline) | 45.3 T-score | Standard Deviation 8.4 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Physical Function (Day 14) | 25.8 T-score | Standard Deviation 3.7 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Satisfaction with Social Role (baseline) | 54.3 T-score | Standard Deviation 6.5 |
| MCD High Force | Patient Reported Outcomes Measurement Information System (PROMIS-43) | PROMIS - Anxiety (Day 14) | 43.4 T-score | Standard Deviation 5.8 |
Procedure Believability Questionnaire
We will ask all participants whether they feel the study procedure would relieve their neck pain using the Procedure Believability Questionnaire. The response choices will be: Strongly believe the procedure will relieve my neck pain; Somewhat believe the procedure will relieve my neck pain; Somewhat believe the procedure will NOT relieve my neck pain; Strongly believe the procedure will NOT relieve my neck pain; and Don't know if the procedure will relieve my neck pain. A baseline (BL) evaluation will be completed based upon treatment description, and compared to assessments following study visit 1 (T1) and study visit 5 (T5) over a 2-week time period.
Time frame: Baseline (BL), Day 1 (Study Visit 1/T1), Day 14 (Study Visit 5/T5)
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| MCD Low Force | Procedure Believability Questionnaire | BL - Strongly will NOT | 0 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T5 - Somewhat WILL | 4 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T5 - Somewhat will not | 1 Participants |
| MCD Low Force | Procedure Believability Questionnaire | BL - Somewhat WILL | 5 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T5 - Strongly will NOT | 6 Participants |
| MCD Low Force | Procedure Believability Questionnaire | BL - Don't know | 8 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T5 - Don't know | 1 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T5 - Missing | 0 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T1 - Strongly WILL | 4 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T1 - Somewhat WILL | 6 Participants |
| MCD Low Force | Procedure Believability Questionnaire | BL - Somewhat will not | 0 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T1 - Somewhat will not | 2 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T1 - Strongly will NOT | 1 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T1 - Don't know | 3 Participants |
| MCD Low Force | Procedure Believability Questionnaire | BL - Strongly WILL | 3 Participants |
| MCD Low Force | Procedure Believability Questionnaire | T5 - Strongly WILL | 4 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T1 - Don't know | 0 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T1 - Strongly WILL | 6 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T5 - Somewhat WILL | 8 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | BL - Strongly will NOT | 0 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | BL - Strongly WILL | 6 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T5 - Somewhat will not | 2 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T1 - Strongly will NOT | 0 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T1 - Somewhat WILL | 10 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T5 - Strongly will NOT | 0 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | BL - Somewhat will not | 1 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T5 - Strongly WILL | 5 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T5 - Don't know | 0 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | BL - Don't know | 4 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T1 - Somewhat will not | 0 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | T5 - Missing | 1 Participants |
| MCD Medium Force | Procedure Believability Questionnaire | BL - Somewhat WILL | 5 Participants |
| MCD High Force | Procedure Believability Questionnaire | T5 - Missing | 2 Participants |
| MCD High Force | Procedure Believability Questionnaire | BL - Strongly WILL | 3 Participants |
| MCD High Force | Procedure Believability Questionnaire | BL - Somewhat WILL | 8 Participants |
| MCD High Force | Procedure Believability Questionnaire | BL - Somewhat will not | 0 Participants |
| MCD High Force | Procedure Believability Questionnaire | BL - Strongly will NOT | 4 Participants |
| MCD High Force | Procedure Believability Questionnaire | BL - Don't know | 4 Participants |
| MCD High Force | Procedure Believability Questionnaire | T1 - Strongly WILL | 4 Participants |
| MCD High Force | Procedure Believability Questionnaire | T1 - Somewhat WILL | 8 Participants |
| MCD High Force | Procedure Believability Questionnaire | T1 - Strongly will NOT | 1 Participants |
| MCD High Force | Procedure Believability Questionnaire | T1 - Don't know | 3 Participants |
| MCD High Force | Procedure Believability Questionnaire | T5 - Strongly WILL | 3 Participants |
| MCD High Force | Procedure Believability Questionnaire | T5 - Somewhat WILL | 6 Participants |
| MCD High Force | Procedure Believability Questionnaire | T5 - Somewhat will not | 0 Participants |
| MCD High Force | Procedure Believability Questionnaire | T5 - Strongly will NOT | 2 Participants |
| MCD High Force | Procedure Believability Questionnaire | T5 - Don't know | 3 Participants |
| MCD High Force | Procedure Believability Questionnaire | T1 - Somewhat will not | 0 Participants |
Cervical Muscle Electromyographic (EMG) Activity
We will describe electromyographic (EMG) activity of superficial neck muscles during delivery of the three manual interventions during visits 3 and 4. EMG measurements are an exploratory outcome variable in this study. RMS EMG TREATMENT DESCRIPTIONS: * (A) Ratio of Root Mean square (RMS) EMG during Treatment at C5/RMS EMG during maximum voluntary contraction (MVC) * (B) RMS EMG during Treatment at C5/RMS EMG during Prone Resting * (C) RMS EMG during Treatment at Occiput (OCC)/RMS EMG during MVC * (D) RMS EMG during Treatment at OCC/ RMS EMG during Prone Resting MUSCLES: * LES-Left erector Spinae Muscle * RES-Right Erector Spinae Muscle * LTRPS- Left Trapezius muscle * RTRPS- Right Trapezius Muscle * LSCM- Left Sternocleido Mastoid muscle * RSCM- Right Sternocleido Mastoid Muscle ACRONYM KEY: * RMS-Root Mean Square Value * MVC-Maximum Voluntary Contraction * C5-Cervical vertebrae contact * OCC-Occipital contact * EMG-Electromyographic activity
Time frame: Day 8 (Study Visit 3), Day 11 (Study Visit 4)
Population: The numbers analyzed in the row differ from the overall due to: (1) Data not collected due to technical problems, (2) Patient did not show up for the visit, (3) 3 participants lost to follow up.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - LSCM | 0.12 ratio | Standard Deviation 0.15 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - RTRPS | 0.42 ratio | Standard Deviation 0.3 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - RTRPS | 1.61 ratio | Standard Deviation 1.21 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - RSCM | 1.47 ratio | Standard Deviation 0.66 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - LSCM | 1.29 ratio | Standard Deviation 0.38 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - RSCM | 1.53 ratio | Standard Deviation 0.95 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - LES | 0.27 ratio | Standard Deviation 0.15 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - LES | 0.21 ratio | Standard Deviation 0.17 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - RES | 0.13 ratio | Standard Deviation 0.1 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - LTRPS | 0.23 ratio | Standard Deviation 0.21 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - RES | 0.28 ratio | Standard Deviation 0.28 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - RTRPS | 0.38 ratio | Standard Deviation 0.27 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - RES | 0.25 ratio | Standard Deviation 0.22 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - LTRPS | 1.36 ratio | Standard Deviation 0.41 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - RSCM | 0.19 ratio | Standard Deviation 0.17 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - LSCM | 0.24 ratio | Standard Deviation 0.26 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - LES | 1.29 ratio | Standard Deviation 0.54 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - LTRPS | 0.23 ratio | Standard Deviation 0.2 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - RES | 1.08 ratio | Standard Deviation 0.51 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - LTRPS | 1.48 ratio | Standard Deviation 0.74 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - RTRPS | 1.26 ratio | Standard Deviation 0.5 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - RTRPS | 0.36 ratio | Standard Deviation 0.29 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - LSCM | 1.65 ratio | Standard Deviation 1.73 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - RSCM | 1.31 ratio | Standard Deviation 0.44 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - LSCM | 0.24 ratio | Standard Deviation 0.24 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - RSCM | 0.15 ratio | Standard Deviation 0.07 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - RSCM | 0.13 ratio | Standard Deviation 0.07 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - LES | 1.41 ratio | Standard Deviation 0.95 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - RES | 1.77 ratio | Standard Deviation 1.43 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - LES | 1.32 ratio | Standard Deviation 1.04 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - LTRPS | 1.38 ratio | Standard Deviation 0.57 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - RTRPS | 1.68 ratio | Standard Deviation 1.72 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - LTRPS | 0.27 ratio | Standard Deviation 0.25 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - LSCM | 1.30 ratio | Standard Deviation 0.26 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - RES | 1.67 ratio | Standard Deviation 0.92 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - RSCM | 1.32 ratio | Standard Deviation 0.34 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - LES | 0.30 ratio | Standard Deviation 0.15 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - RES | 0.20 ratio | Standard Deviation 0.18 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - LTRPS | 1.41 ratio | Standard Deviation 0.44 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - LTRPS | 0.24 ratio | Standard Deviation 0.23 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - RTRPS | 0.43 ratio | Standard Deviation 0.27 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - RTRPS | 1.29 ratio | Standard Deviation 0.18 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - LSCM | 0.11 ratio | Standard Deviation 0.09 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - RSCM | 0.22 ratio | Standard Deviation 0.19 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - LES | 0.25 ratio | Standard Deviation 0.2 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - LES | 1.34 ratio | Standard Deviation 0.83 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - LSCM | 1.36 ratio | Standard Deviation 0.5 |
| MCD Low Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - RES | 2.17 ratio | Standard Deviation 2.2 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - LSCM | 1.68 ratio | Standard Deviation 1.27 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - LTRPS | 1.31 ratio | Standard Deviation 0.19 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - LSCM | 0.15 ratio | Standard Deviation 0.15 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - LES | 0.25 ratio | Standard Deviation 0.15 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - RTRPS | 1.14 ratio | Standard Deviation 0.38 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - LTRPS | 0.23 ratio | Standard Deviation 0.12 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - RSCM | 0.17 ratio | Standard Deviation 0.16 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - LSCM | 1.82 ratio | Standard Deviation 0.97 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - RSCM | 1.83 ratio | Standard Deviation 1.13 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - RSCM | 0.19 ratio | Standard Deviation 0.17 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - RSCM | 1.55 ratio | Standard Deviation 1.15 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - RTRPS | 0.37 ratio | Standard Deviation 0.26 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - LSCM | 0.27 ratio | Standard Deviation 0.22 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - LES | 0.27 ratio | Standard Deviation 0.2 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - LES | 1.54 ratio | Standard Deviation 1.06 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - LES | 0.26 ratio | Standard Deviation 0.22 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - RES | 0.30 ratio | Standard Deviation 0.22 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - LES | 0.22 ratio | Standard Deviation 0.19 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - RES | 0.28 ratio | Standard Deviation 0.17 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - LTRPS | 0.21 ratio | Standard Deviation 0.2 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - RES | 1.41 ratio | Standard Deviation 0.25 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - RTRPS | 1.31 ratio | Standard Deviation 0.22 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - RTRPS | 0.32 ratio | Standard Deviation 0.29 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - LES | 1.71 ratio | Standard Deviation 1.54 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - LTRPS | 1.47 ratio | Standard Deviation 0.6 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - LSCM | 0.17 ratio | Standard Deviation 0.13 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - RES | 0.24 ratio | Standard Deviation 0.15 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - LES | 2.03 ratio | Standard Deviation 1.46 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - RSCM | 0.22 ratio | Standard Deviation 0.24 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - LTRPS | 0.22 ratio | Standard Deviation 0.2 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - RTRPS | 1.38 ratio | Standard Deviation 0.28 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - LES | 1.68 ratio | Standard Deviation 1.12 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - LTRPS | 1.80 ratio | Standard Deviation 0.85 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - RSCM | 0.18 ratio | Standard Deviation 0.22 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - RES | 1.32 ratio | Standard Deviation 0.65 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - LTRPS | 0.19 ratio | Standard Deviation 0.12 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - LSCM | 1.48 ratio | Standard Deviation 0.54 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - LTRPS | 1.40 ratio | Standard Deviation 0.7 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - LSCM | 0.22 ratio | Standard Deviation 0.18 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - RTRPS | 0.28 ratio | Standard Deviation 0.22 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - RTRPS | 1.36 ratio | Standard Deviation 0.42 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - RES | 2.06 ratio | Standard Deviation 0.92 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - RSCM | 1.48 ratio | Standard Deviation 0.43 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - LSCM | 2.38 ratio | Standard Deviation 1.86 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - RTRPS | 0.36 ratio | Standard Deviation 0.26 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - RES | 2.53 ratio | Standard Deviation 2.12 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - RSCM | 1.54 ratio | Standard Deviation 0.63 |
| MCD Medium Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - RES | 0.34 ratio | Standard Deviation 0.14 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - RSCM | 1.32 ratio | Standard Deviation 0.4 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - LES | 0.31 ratio | Standard Deviation 0.25 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - RES | 0.16 ratio | Standard Deviation 0.13 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - LTRPS | 0.22 ratio | Standard Deviation 0.2 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - RTRPS | 0.29 ratio | Standard Deviation 0.25 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - LSCM | 0.14 ratio | Standard Deviation 0.1 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (A) - RSCM | 0.13 ratio | Standard Deviation 0.12 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - LES | 1.40 ratio | Standard Deviation 0.76 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - RES | 2.13 ratio | Standard Deviation 1.78 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - RTRPS | 1.20 ratio | Standard Deviation 0.22 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - LSCM | 1.78 ratio | Standard Deviation 1.4 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - RSCM | 1.41 ratio | Standard Deviation 0.66 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - LES | 0.25 ratio | Standard Deviation 0.19 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - RES | 0.16 ratio | Standard Deviation 0.16 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - LTRPS | 0.24 ratio | Standard Deviation 0.22 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - RTRPS | 0.31 ratio | Standard Deviation 0.29 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - LSCM | 0.12 ratio | Standard Deviation 0.09 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (C) - RSCM | 0.12 ratio | Standard Deviation 0.08 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - LES | 1.49 ratio | Standard Deviation 0.88 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - RES | 1.58 ratio | Standard Deviation 1.38 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - LTRPS | 1.24 ratio | Standard Deviation 0.19 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - RTRPS | 1.21 ratio | Standard Deviation 0.16 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - LSCM | 1.69 ratio | Standard Deviation 0.98 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (D) - RSCM | 1.49 ratio | Standard Deviation 0.75 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - LES | 0.27 ratio | Standard Deviation 0.19 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - RES | 0.20 ratio | Standard Deviation 0.22 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - LTRPS | 0.25 ratio | Standard Deviation 0.24 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - RTRPS | 0.30 ratio | Standard Deviation 0.25 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - LSCM | 0.13 ratio | Standard Deviation 0.09 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (A) - RSCM | 0.15 ratio | Standard Deviation 0.12 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - LES | 1.75 ratio | Standard Deviation 1.5 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - RES | 1.81 ratio | Standard Deviation 1.53 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - LTRPS | 1.84 ratio | Standard Deviation 1.69 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - RTRPS | 1.27 ratio | Standard Deviation 0.13 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - LSCM | 2.20 ratio | Standard Deviation 1.29 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (B) - RSCM | 1.67 ratio | Standard Deviation 0.92 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - LES | 0.22 ratio | Standard Deviation 0.17 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - RES | 0.15 ratio | Standard Deviation 0.17 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - LTRPS | 0.21 ratio | Standard Deviation 0.24 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - RTRPS | 0.31 ratio | Standard Deviation 0.26 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - LSCM | 0.12 ratio | Standard Deviation 0.09 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (C) - RSCM | 0.14 ratio | Standard Deviation 0.17 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - LES | 1.59 ratio | Standard Deviation 1.43 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - RES | 1.76 ratio | Standard Deviation 1.12 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - LTRPS | 1.49 ratio | Standard Deviation 0.56 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - RTRPS | 1.31 ratio | Standard Deviation 0.14 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 4 - (D) - LSCM | 2.37 ratio | Standard Deviation 2.57 |
| MCD High Force | Cervical Muscle Electromyographic (EMG) Activity | Visit 3 - (B) - LTRPS | 1.27 ratio | Standard Deviation 0.37 |
Patient Satisfaction Questionnaire
Participants' satisfaction with study procedures and staff were assessed at Study Visit 5 using standard questions. Participants rated their satisfaction with various elements of the study (e.g., treatments received, clinicians) using a 5 category response from 1 (strongly satisfied) to 5 (strongly dissatisfied) with categories collapsed into satisfied (categories 1 and 2) or not satisfied (categories 3, 4 or 5) for interpretation.
Time frame: Day 14 (Study Visit 5)
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| MCD Low Force | Patient Satisfaction Questionnaire | Satisfied with Treatment | 7 Participants |
| MCD Low Force | Patient Satisfaction Questionnaire | Satisfied with Clinician | 14 Participants |
| MCD Medium Force | Patient Satisfaction Questionnaire | Satisfied with Treatment | 9 Participants |
| MCD Medium Force | Patient Satisfaction Questionnaire | Satisfied with Clinician | 14 Participants |
| MCD High Force | Patient Satisfaction Questionnaire | Satisfied with Treatment | 15 Participants |
| MCD High Force | Patient Satisfaction Questionnaire | Satisfied with Clinician | 15 Participants |